VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, today announced that it has received a $72.75 ...

FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems (“Aspect”) (“the Company”), a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 ...

VANCOUVER, British Columbia, April 02, 2026--(BUSINESS WIRE)--Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a ...

Aspect Biosystems, a biotechnology company that conducts 3D bioprinting of human tissues, has raised $26 million CAD ($20 million USD) for its Series A round of funding. The new capital marks the ...

Proceeds will accelerate development of functional cures for people living with serious diseases and deepen Aspect’s full-stack tissue therapeutic platform VANCOUVER, British Columbia — Aspect ...

Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect Biosystems Aspect will lead development, manufacturing and commercialisation, and Novo Nordisk will ...

Preclinical data highlight the potential of Aspect’s adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency VANCOUVER, British Columbia — Aspect ...

Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada. The ...